Frequently Asked Questions
Does red clover actually reduce hot flushes?
The clinical evidence suggests that red clover may reduce the frequency of hot flushes in some women, but the findings have varied between studies. Some systematic reviews have reported a statistically significant reduction, while others have found smaller or less certain effects.
What dosage of red clover is typically studied?
Clinical studies have used a range of doses rather than one standard amount. A 2026 systematic review reported daily red clover isoflavone doses ranging from approximately 37 mg to 160 mg, while earlier trials commonly examined doses around 40–80 mg daily. The dose used in a study should not automatically be treated as the recommended dose for a different product.
Is red clover safe for everyone to take?
No supplement can be assumed to be suitable for everyone. Red clover contains phytoestrogens, so women with a history of hormone-sensitive cancer or another hormone-sensitive condition should speak with their doctor or pharmacist before using it. It is also important to discuss herbal supplements with a healthcare professional if you take medicines or have other health concerns.
What is ERr 731®?
ERr 731® is a specific, standardised red clover extract that has been investigated in clinical studies. Research involving ERr 731® relates to this particular extract and should not automatically be applied to all red clover products. For more information, see the dedicated ERr 731® ingredient page.
How does red clover compare to hormone replacement therapy?
Red clover and menopausal hormone therapy (MHT, also known as HRT) are different approaches and should not be considered equivalent. Red clover has been studied for menopausal symptoms, but the evidence is variable, while MHT is a medical treatment that may be appropriate for some women following individual assessment. If you're considering options for hot flushes, discuss the potential benefits, risks and suitability of different approaches with your healthcare professional.